JPM
55
3
NWSA
70
8
HUM
46
10
MU
52
4
IPG
50
2
O
39
9
USB
53
3
UNH
26
13
MLM
64
10
AFL
41
2
AAL
17
3
VFC
53
19
VIX
60
-19
NTRS
44
4
WM
56
3
AIZ
71
5
TEL
85
2
THC
55
6
APD
45
6
GOOGL
47
7
JPM
55
3
NWSA
70
8
HUM
46
10
MU
52
4
IPG
50
2
O
39
9
USB
53
3
UNH
26
13
MLM
64
10
AFL
41
2
AAL
17
3
VFC
53
19
VIX
60
-19
NTRS
44
4
WM
56
3
AIZ
71
5
TEL
85
2
THC
55
6
APD
45
6
GOOGL
47
7
Financhill
Back

Apellis Pharmaceuticals Vs. Nektar Therapeutics Industry Stock Comparison

Buy
60

APLS
Apellis Pharmaceuticals

Last Price:
$24.50
Seasonality Move:
-5.27%
Buy
51

NKTR
Nektar Therapeutics

Last Price:
$22.85
Seasonality Move:
-1.52%
Buy
60
Apellis Pharmaceuticals (APLS) is a Buy

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $24.26. The Score for APLS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Nektar Therapeutics (NKTR) is a Buy

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $23.27. The Score for NKTR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $24.26
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $23.27
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.94 Buy
Relative Strength Index (14 RSI): 75.67 Buy
Chaikin Money Flow: 3112355 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.93 - 21.13) Buy
Bollinger Bands (100): (17.23 - 21.93) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.6 Buy
Relative Strength Index (14 RSI): 53.67 Buy
Chaikin Money Flow: 268156 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.03 - 25.35) Sell
Bollinger Bands (100): (7.83 - 21.15) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.74 Buy
20-day SMA: 19.98 Buy
50-day SMA: 18.89 Buy
200-day SMA: 24.63 Sell
8-day EMA: 21.43 Buy
20-day EMA: 20.22 Buy
50-day EMA: 19.57 Buy
200-day EMA: 25.01 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.27 Buy
20-day SMA: 24.03 Sell
50-day SMA: 18.44 Buy
200-day SMA: 14.96 Buy
8-day EMA: 16.22 Buy
20-day EMA: 8.9 Buy
50-day EMA: 4.1 Buy
200-day EMA: 1.1 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $1.11 per share, an increase this year of $1.21 per share, and a decrease next year of $0.63 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.99 per share, and a decrease next year of $1.16 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):